BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27575542)

  • 1. Azithromycin for the Treatment of Obliterative Bronchiolitis after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Yadav H; Peters SG; Keogh KA; Hogan WJ; Erwin PJ; West CP; Kennedy CC
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2264-2269. PubMed ID: 27575542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.
    Cheng GS; Storer B; Chien JW; Jagasia M; Hubbard JJ; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Crothers K; Pusic I; Lee SJ; Williams KM
    Ann Am Thorac Soc; 2016 Nov; 13(11):1932-1939. PubMed ID: 27513368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.
    Bergeron A; Chevret S; Granata A; Chevallier P; Vincent L; Huynh A; Tabrizi R; Labussiere-Wallet H; Bernard M; Chantepie S; Bay JO; Thiebaut-Bertrand A; Thepot S; Contentin N; Fornecker LM; Maillard N; Risso K; Berceanu A; Blaise D; Peffault de La Tour R; Chien JW; Coiteux V; Socié G;
    JAMA; 2017 Aug; 318(6):557-566. PubMed ID: 28787506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.
    Williams KM; Cheng GS; Pusic I; Jagasia M; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Chien JW; Jacobsohn DA; Pavletic SZ; Martin PJ; Storer BE; Inamoto Y; Chai X; Flowers MED; Lee SJ
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):710-716. PubMed ID: 26475726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients.
    Shitrit D; Bendayan D; Gidon S; Saute M; Bakal I; Kramer MR
    J Heart Lung Transplant; 2005 Sep; 24(9):1440-3. PubMed ID: 16143268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study.
    Gerhardt SG; McDyer JF; Girgis RE; Conte JV; Yang SC; Orens JB
    Am J Respir Crit Care Med; 2003 Jul; 168(1):121-5. PubMed ID: 12672648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis.
    Kingah PL; Muma G; Soubani A
    Clin Transplant; 2014 Aug; 28(8):906-10. PubMed ID: 24931185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation.
    Corris PA; Ryan VA; Small T; Lordan J; Fisher AJ; Meachery G; Johnson G; Ward C
    Thorax; 2015 May; 70(5):442-50. PubMed ID: 25714615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
    Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T
    Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.
    Vanaudenaerde BM; Meyts I; Vos R; Geudens N; De Wever W; Verbeken EK; Van Raemdonck DE; Dupont LJ; Verleden GM
    Eur Respir J; 2008 Oct; 32(4):832-43. PubMed ID: 18827151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of azithromycin on bronchiolitis obliterans syndrome in posttransplant recipients: A systematic review and meta-analysis.
    Hao X; Peng C; Lian W; Liu H; Fu G
    Medicine (Baltimore); 2022 Jul; 101(28):e29160. PubMed ID: 35839027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of maintenance azithromycin on established bronchiolitis obliterans syndrome in lung transplant patients.
    Porhownik NR; Batobara W; Kepron W; Unruh HW; Bshouty Z
    Can Respir J; 2008; 15(4):199-202. PubMed ID: 18551201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT--a randomized double-blinded placebo-controlled study.
    Lam DC; Lam B; Wong MK; Lu C; Au WY; Tse EW; Leung AY; Kwong YL; Liang RH; Lam WK; Ip MS; Lie AK
    Bone Marrow Transplant; 2011 Dec; 46(12):1551-6. PubMed ID: 21317934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of FEV1 for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
    Ahn JH; Jo KW; Song JW; Shim TS; Lee SW; Lee JS; Kim DY; Lee JH; Lee JH; Choi Y; Lee KH
    Clin Transplant; 2015 Dec; 29(12):1133-9. PubMed ID: 26383085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of azithromycin in bronchiolitis obliterans syndrome.
    Gan CT; Ward C; Meachery G; Lordan JL; Fisher AJ; Corris PA
    BMJ Open Respir Res; 2019; 6(1):e000465. PubMed ID: 31673366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated?
    Bryant DH
    Eur Respir J; 2005 Mar; 25(3):402-4. PubMed ID: 15738280
    [No Abstract]   [Full Text] [Related]  

  • 17. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study.
    Khalid M; Al Saghir A; Saleemi S; Al Dammas S; Zeitouni M; Al Mobeireek A; Chaudhry N; Sahovic E
    Eur Respir J; 2005 Mar; 25(3):490-3. PubMed ID: 15738293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome.
    Verleden GM; Vanaudenaerde BM; Dupont LJ; Van Raemdonck DE
    Am J Respir Crit Care Med; 2006 Sep; 174(5):566-70. PubMed ID: 16741151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung transplantation: the role of azithromycin in the management of patients with bronchiolitis obliterans syndrome.
    Fietta AM; Meloni F
    Curr Med Chem; 2008; 15(7):716-23. PubMed ID: 18336286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.
    Jain R; Hachem RR; Morrell MR; Trulock EP; Chakinala MM; Yusen RD; Huang HJ; Mohanakumar T; Patterson GA; Walter MJ
    J Heart Lung Transplant; 2010 May; 29(5):531-7. PubMed ID: 20133163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.